AZTA
HEALTHCAREAzenta Inc
Live · NASDAQ · May 9, Close
What's Moving AZTA Today?
No stock-specific AI insight has been generated for AZTA yet. Check back soon — insights are generated from recent news analysis.
52-Week Range
$18.38
Fundamentals
Trading
AZTA News
21 articles- Azenta, Inc. Q2 2026 Earnings Call SummaryMoby·May 6, 2026
- Azenta Q2 Earnings Call HighlightsMarketbeat·May 6, 2026
- Azenta Reports Second Quarter Results for Fiscal 2026, Ended March 31, 2026, Updates Full Year Fiscal 2026 Guidance, and Extends Long-Range Plan to 2029Yahoo Finance·May 5, 2026
- How The Azenta (AZTA) Investment Narrative Is Shifting As Analysts Recut Valuation TargetsYahoo Finance·May 3, 2026
- Assessing Azenta (AZTA) Valuation After Recent Share Price VolatilityYahoo Finance·May 3, 2026
- Evercore Cuts Azenta (AZTA) Price Target, Keeps Outperform RatingYahoo Finance·Apr 30, 2026
- Azenta Announces Fiscal 2026 Second Quarter Conference Call and WebcastYahoo Finance·Apr 29, 2026
- Azenta (AZTA) Fell on Operational Challenges and Uneven ExecutionYahoo Finance·Apr 28, 2026
- 2 Cash-Heavy Stocks on Our Buy List and 1 We Turn DownYahoo Finance·Apr 24, 2026
- 1 Healthcare Stock to Target This Week and 2 We IgnoreYahoo Finance·Apr 22, 2026
- 3 Stocks Under $50 We’re Skeptical OfYahoo Finance·Apr 17, 2026
- Azenta (AZTA) Stock Drops 13% After-Hours — What's Happening?Benzinga·Apr 17, 2026
- Assessing Azenta (AZTA) Valuation After A Short-Term Rebound And Longer-Term Share Price WeaknessYahoo Finance·Apr 7, 2026
- Azenta Life Sciences Announces Leadership Transition to Accelerate Gene Synthesis Strategy and Multiomics ExecutionYahoo Finance·Apr 7, 2026
- Azenta, 10x Genomics, PacBio, Oscar Health, and Moderna Shares Plummet, What You Need To KnowYahoo Finance·Mar 27, 2026
- Q4 Earnings Highs And Lows: Azenta (NASDAQ:AZTA) Vs The Rest Of The Drug Development Inputs & Services StocksYahoo Finance·Mar 24, 2026
- 1 Cash-Producing Stock with Exciting Potential and 2 We IgnoreYahoo Finance·Mar 20, 2026
- 3 Unprofitable Stocks That Concern UsYahoo Finance·Mar 19, 2026
- Azenta Buys UK Biocentre As Valuation Screens Cheap Despite Weak MomentumYahoo Finance·Mar 16, 2026
- Has Azenta (AZTA) Fallen Too Far After Recent Share Price Weakness?Yahoo Finance·Mar 14, 2026
- Azenta Details UK Biocentre Buyout to Expand Europe Biobanking, Near-Term EBITDA Dilution SeenMarketbeat·Mar 12, 2026
All 21 articles loaded
Price Data
52-Week Range
$18.38
Fundamentals
Trading
About Azenta Inc
Azenta Inc. is a premier provider of sample management solutions and life science tools, dedicated to enhancing laboratory efficiencies for the biotechnology and pharmaceutical industries. By leveraging innovative automated solutions, comprehensive biorepository services, and advanced storage technologies, the company enables clients to accelerate drug discovery while adhering to stringent regulatory requirements. With a strong emphasis on cutting-edge technology and strategic partnerships, Azenta is well-positioned to seize growth opportunities in the expanding global life sciences market. Its commitment to advancing scientific research through sophisticated products further solidifies its competitive advantage in biobanking and sample management.